Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4)

 EDITORIAL 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):245-7

Communicating across the boundaries

Duatti A., Smith S. V.


 ADVANCES IN RADIONUCLIDE THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):248-64

Advances in cancer therapy with radiolabeled monoclonal antibodies

Goldenberg D. M., Sharkey R. M.


 ADVANCES IN RADIONUCLIDE THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):265-71

Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate

Bakker W. H., Breeman W. A. P., Kwekkeboom D. J., De Jong L. C., Krenning E. P.


 ADVANCES IN RADIONUCLIDE THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):272-87

Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy

Pelosi G., Volante M., Papotti M., Sonzogni A., Masullo M., Viale G.


 ADVANCES IN RADIONUCLIDE THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):288-95

Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides

Cremonesi M., Ferrari M., Bodei L., Tosi G., Paganelli G.


 ADVANCES IN RADIONUCLIDE THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):296-309

Vascular tumor targeting

Ahlskog J., Paganelli G., Neri D.


 ADVANCES IN RADIONUCLIDE THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):310-21

Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy

Panigone S., Nunn A. D.


 ADVANCES IN RADIONUCLIDE THERAPY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):322-9

Current status and perspectives in alpha radioimmunotherapy

Chérel M., Davodeau F., Kraeber-Bodéré F., Chatal J. F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):330-3

Platelet function after single [153Sm]EDTMP therapy in prostate cancer

Weiss K., Palumbo B., Palumbo I., Palumbo R., Granegger S., Hiltunen J., Sinzinger H.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):334-43

Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods

Sobal G., Resch U., Tatzber F., Sinzinger H.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):344-7

Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan

Giovanella L., Squin N., Ghelfo A., Ceriani L.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):348-54

Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma

Zerva B., Koutsikos J., Palestidis C., Kounadi E., Gerali S.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):355-62

[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast

Minutoli F., Herberg A., Spadaro P., Restifo Pecorella G., Baldari S., Aricò D., Altavilla G., Baldari S.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 December;50(4):363-70

Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications

Courbon F., Caselles O., Zerdoud S., Duthil P., Regis H., Berry I., Caron P.


inizio pagina